Early awareness and alert systems for medical technologies in Israel

International Journal of Technology Assessment in Health Care

Volumn 28, Issue 3, 2012, Pages 333-338

  Tal, Orna ^a   Hakak, Nina ^b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b MINISTRY OF HEALTH   (Israel)

Author keywords

Dilemmas in health policy; Health policy; Horizon scanning; Medical technologies

Indexed keywords

ALERT SYSTEMS; COST CONTAINMENT; DECISION MAKERS; EMERGING TECHNOLOGIES; EXPERT CONSULTATION; FUTURE TRENDS; HEALTH POLICY; HEALTH SERVICES; HEALTH STATUS; HORIZON SCANNING; LONG TERM PLANNING; MEDICAL TECHNOLOGIES; TIME SPAN;

HEALTH CARE; INTERNATIONAL COOPERATION; TECHNOLOGICAL FORECASTING;

HEALTH INSURANCE;

ARTICLE; AWARENESS; DECISION MAKING; GOVERNMENT REGULATION; HEALTH CARE PLANNING; INTROSPECTION; ISRAEL; MEDICAL TECHNOLOGY;

AWARENESS; BIOMEDICAL TECHNOLOGY; HEALTH POLICY; ISRAEL; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84866381826     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462312000396     Document Type: Article

References (21)

1. Douw K, Vondeling H. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems. Int J Technol Assess Health Care. 2006;22:177-183.
2. Golan O, Hansen P, Kaplan G, Tal O. Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights? Health Policy. 2011;102:126-135.
3. Greenberg D, Siebzehner MI, Pliskin JS. The process of updating the National List of Health Services in Israel: Is it legitimate? Is it fair? Int J Technol Assess Health Care. 2009;25:255-261. doi:10.1017/S026646230999016X
4. Guttman N, Shalev C, Kaplan G, et al. What should be given a priority-costly medications for relatively few people or inexpensive ones for many? The Health Parliament Public Consultation Initiative in Israel. Health Expect. 2008;11:177-188. (Pubitemid 351725001)
5. Ham C, Locock L. International approaches to priority setting in health care. Handbook Series 25. Birmingham, UK: Health Services Management Center, University of Birmingham; 1998.
6. Ibargoyen-Roteta N, Gutierrez-Ibarluzea I, Benguria-Arrate G, Galnares-Cordero L, Asua J. Differences in the identification process for new and emerging health technologies: Analysis of the EuroScan database. Int J Technol Assess Health Care. 2009;25:367-373.
7. Murphy K, Packer C, Stevens A, Simpson S. Effective early warning systems for new and emerging health technologies: Developing an evaluation framework and an assessment of current systems. Int J Technol Assess Health Care. 2007;23:324-330. (Pubitemid 46956886)
8. Nachtnebel A, Geiger-Gritsch S, Hintringer K, Wild C. Scanning the horizon-Development and implementation of an early awareness system for anticancer drugs in Austria. Health Policy. 2012;104:1-11.
9. National Health Insurance Law, State of Israel, 1994.
10. Packer C. Horizon scanning in England and the EuroScan collaboration. March 2009. http://finohta.stakes.fi/NR/rdonlyres/F3556F0C-FA37-4417-989D- A6A15F90DD07/0/PackerClaire-HelsinkiMUMMworkshopMarch2009.pdf (accessed March 28, 2012).
11. Packer C, Simpson S, Stevens A, on behalf of EuroScan: The European Information Network on New and Changing Health Technologies. International diffusion of new health technologies: A ten-country analysis of six health technologies. Int J Technol Assess Health Care. 2006;22:419-428. (Pubitemid 44622961)
12. Robert G, Stevens A, Gabbay J. 'Early warning systems' for identifying new healthcare technologies. Health Technol Assess. 1999;3:1-108.
13. Shani S, Klang SH, Haran B, Shemer J. Updating the national list of reimbursed drugs in an era of limited resources. Pharm World Sci. 1999;21:A13.
14. Shani S, Siebzehner MI, Luxenburg O, Shemer J. Setting priorities for the adoption of health technologies on a national level-the Israeli experience. Health Policy. 2000;54:169-185. (Pubitemid 32012607)
15. Shemer J, Shani M, Tamir O, Siebzehner MI. Health technology assessment management in Israel-HTA in action. Int J Technol Assess Health Care. 2009;25(Suppl 1):134-139.
16. Simpson S, Hiller J, Gutierrez-Ibarluzea I, et al. A toolkit for the identification and assessment of new and emerging health technologies. 2009. EuroScan. Birmingham. http://euroscan.org.uk/news/sed-rhoncus/(accessed December 21, 2011).
17. Tal O, Marom E, Applbaum Y, Rasooly I. Israel's healthcare system: Looking forward to the year 2020-Preparing a healthcare model. Logist Health Care. 2007;4:5-10.
18. Tal O, Sheffer N, Vaknin S. Parameters for allocation of Expensive Medical Devices (EMD) as a national regulatory mechanism. Harefuah. 2008;147:359-362
19. Tal O. Forecasting medical technologies-a global overview. Harefuah. 2011;150:185-189.
20. Tamary H, Bar-Yam R, Shalmon L, et al. Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients. Br J Haematol. 2000;111:338-343. Erratum in: Br J Haematol. 2001;112:829.
21. Taub Center. http://taubcenter.org.il/index.php/category/data-sets/lang/ he/(13/7/11 (accessed December 28, 2011).